VINTABIO

VintaBio is a life sciences company with unmatched industry expertise helping alleviate the viral vector bottleneck in cell and gene therapy development. We specialize in customized process development, GMP manufacturing, and quality control services for cell and gene therapies... VintaBio's development and manufacturing team has over a century of experience in the cell and gene therapy space and its members have played key roles in the development of the most advanced therapies on the market today. Located in the historic Navy Yards of Philadelphia - the epicenter of cell and gene therapy innovation - VintaBio specializes in developing and manufacturing consistent, high-quality viral vectors, a vital and currently underserved area of CGT development. The company was founded by Junwei Sun and Dr. Shangzhen Zhou, who led development of the AAV vectors behind the first two FDA-approved gene therapies, as well as the lentiviral vector for the first FDA-approved cell therapy. VintaBio has..

Primary location: Philadelphia United States